Cost comparison of liquid versus particulate embolic agents for middle meningeal artery embolization in chronic subdural hematoma.

ABSTRACT: IntroductionChronic subdural hematomas (cSDH) are increasingly recognized as a major cause of morbidity in aging populations. Procedural Innovations such as middle meningeal artery embolization (MMAE) are becoming more widely adopted for cSDH treatment. While embolization reduces hematoma recurrence, the economic cost of different embolic agents remains unclear. This study evaluates inpatient procedural costs associated with particulate versus liquid embolic materials in MMAE for cSDH.MethodsA retrospective cohort study was conducted at a Comprehensive Stroke Center, including patients who underwent MMAE for cSDH between January 2019 and January 2024. Actual hospital expenditure data was used to assess total procedural and material-specific costs. Clinical outcomes, such as modified Rankin

SUBMITTER: Gajjar AA 

PROVIDER: S-EPMC12343547 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature